Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nucleolar RNA SNORA57 (SNORA57) is a non-coding RNA molecule classified as a small nucleolar RNA (snoRNA), located on chromosome 10 (position 26,789,017-26,789,157, forward strand)[1][3]. This gene encodes an RNA component involved in the post-transcriptional modification of other small nuclear RNAs, particularly guiding the pseudouridylation of specific uridine residues in target RNAs. SNORA57 is not a therapeutic target such as a receptor, enzyme, or transporter, but rather plays a role in the chemical modification of RNA, contributing to the proper maturation and function of ribosomal and spliceosomal RNAs[3]. Key context: - ENSG00000223027/LOC124900293 is not a protein-coding gene and is not considered a direct drug target. - Its main function is as a guide RNA for RNA modification, which is essential for cellular RNA processing[3]. - There is no current evidence linking SNORA57 directly to disease mechanisms, drug interactions, or recognized roles as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nucleolar RNA SNORA57 (SNORA57).